• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌委员会的质量研究:术前与病理分期之间一致性的研究。

Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging.

机构信息

Department of Thoracic Surgery, Lung Functional Unit, Hospital Universitari de Bellvitge and Hospital Duran i Reynals-Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Eur J Cardiothorac Surg. 2010 Mar;37(3):540-5. doi: 10.1016/j.ejcts.2009.07.026. Epub 2009 Aug 21.

DOI:10.1016/j.ejcts.2009.07.026
PMID:19699648
Abstract

OBJECTIVE

Accurate preoperative staging is essential to provide the best treatment for lung cancer. The objective of the present study was to determine agreement between preoperative and surgical-pathological staging and to analyse the impact of any disparity on treatment.

METHODS

This is a descriptive study of a series of 176 lung cancer cases treated by surgery between 2005 and 2007. Preoperative staging was based on clinical information and computed tomography (CT), positron emission tomography (PET), PET-CT, bronchoscopy and mediastinoscopy. In all cases, surgical-pathological staging was based on the analysis of surgical samples and the findings during surgery. Both preoperative and pathological stage determination were based on the TNM (tumour, node, metastasis) classification established in 1997. Concordance was measured by calculating agreement rates and the kappa value.

RESULTS

Preoperative and surgical-pathological staging agreed in 102 cases, an agreement rate of 58% and kappa value of 0.54 (95% confidence interval (CI) 0.44-0.63). The highest kappa value (0.68, 95% CI 0.53-0.82) was obtained in stage IA patients. Patients who underwent PET or PET-CT had a better kappa index (0.56, 95% CI 0.45-0.67, vs 0.39, 95% CI 0.21-0.56). Surgical-pathological staging validated surgery in 145 cases (82%), while 21 (12%) were revised to stage IIIA N2 and 10 (6%) to non-surgical stages.

CONCLUSIONS

Global agreement between preoperative and surgical-pathological staging was moderate. The best agreement was found in stages IV and IA.

摘要

目的

准确的术前分期对于为肺癌患者提供最佳治疗至关重要。本研究的目的是确定术前和手术病理分期之间的一致性,并分析任何差异对治疗的影响。

方法

这是一项对 2005 年至 2007 年间接受手术治疗的 176 例肺癌病例的描述性研究。术前分期基于临床信息和计算机断层扫描(CT)、正电子发射断层扫描(PET)、PET-CT、支气管镜和纵隔镜检查。在所有病例中,手术病理分期均基于手术样本分析和手术期间的发现。术前和病理分期均基于 1997 年建立的 TNM(肿瘤、淋巴结、转移)分类。通过计算一致性率和kappa 值来衡量一致性。

结果

102 例患者的术前和手术病理分期一致,一致性率为 58%,kappa 值为 0.54(95%置信区间(CI)0.44-0.63)。IA 期患者的 kappa 值最高(0.68,95%CI 0.53-0.82)。接受 PET 或 PET-CT 的患者具有更好的 kappa 指数(0.56,95%CI 0.45-0.67,vs 0.39,95%CI 0.21-0.56)。手术病理分期在 145 例(82%)患者中验证了手术,21 例(12%)患者被修订为 IIIA N2 期,10 例(6%)患者被修订为非手术期。

结论

术前和手术病理分期之间的总体一致性为中度。IA 期和 IV 期的一致性最好。

相似文献

1
Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging.肺癌委员会的质量研究:术前与病理分期之间一致性的研究。
Eur J Cardiothorac Surg. 2010 Mar;37(3):540-5. doi: 10.1016/j.ejcts.2009.07.026. Epub 2009 Aug 21.
2
Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.肺癌临床与病理肿瘤、淋巴结及转移分期的比较:530例患者的15年经验
Minerva Chir. 2011 Dec;66(6):509-16.
3
Preoperative staging of lung cancer with combined PET-CT.采用PET-CT联合检查对肺癌进行术前分期
N Engl J Med. 2009 Jul 2;361(1):32-9. doi: 10.1056/NEJMoa0900043.
4
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.术前胸内淋巴结分期在非小细胞肺癌患者中的应用:正电子发射断层扫描和计算机断层扫描的准确性。
Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22.
5
ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.欧洲胸外科医师协会非小细胞肺癌术前淋巴结分期指南。
Eur J Cardiothorac Surg. 2007 Jul;32(1):1-8. doi: 10.1016/j.ejcts.2007.01.075. Epub 2007 Apr 19.
6
Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.计算机断层扫描和正电子发射断层扫描筛查的I期肺癌患者常规纵隔镜检查的成本效益
J Thorac Cardiovasc Surg. 2006 Apr;131(4):822-9; discussion 822-9. doi: 10.1016/j.jtcvs.2005.10.045. Epub 2006 Mar 2.
7
[Comparison of clinical and surgico-pathological TNM stage of 2007 lung cancer patients].[2007年肺癌患者临床与外科病理TNM分期的比较]
Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):551-3.
8
The multidisciplinarity of stage III non-small cell lung cancer.III期非小细胞肺癌的多学科性。
Eur J Cancer. 2009 Sep;45 Suppl 1:92-105. doi: 10.1016/S0959-8049(09)70021-8.
9
Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung.扩大颈部纵隔镜检查在左肺支气管源性癌分期中的应用
Eur J Cardiothorac Surg. 2008 Nov;34(5):1081-4. doi: 10.1016/j.ejcts.2008.07.034. Epub 2008 Aug 29.
10
Mediastinal staging of lung cancer. Is mediastinoscopy still essential?肺癌的纵隔分期。纵隔镜检查仍然必不可少吗?
Dan Med Bull. 1995 Apr;42(2):192-4.

引用本文的文献

1
New insights into spectral histopathology: infrared-based scoring of tumour aggressiveness of squamous cell lung carcinomas.光谱组织病理学的新见解:基于红外技术对肺鳞状细胞癌肿瘤侵袭性的评分
Chem Sci. 2019 Mar 5;10(15):4246-4258. doi: 10.1039/c8sc04320e. eCollection 2019 Apr 21.
2
Clinical staging of NSCLC: current evidence and implications for adjuvant chemotherapy.非小细胞肺癌的临床分期:当前证据及对辅助化疗的意义
Ther Adv Med Oncol. 2017 Sep;9(9):599-609. doi: 10.1177/1758834017722746. Epub 2017 Aug 2.